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1494 The Journal of Thoracic and CardAccumulating clinical1-3 and basic4,5 evidence with regard to the internalthoracic artery (ITA) as a viable graft has revealed that this arterial graft forcoronary bypass surgery is not a simple conduit to transport blood to the
myocardium. It has a character of the major collateral pathway6 with active biologic
potency, such as immunity from the atherosclerotic process, active dilatation and
resultant arterial wall remodeling, excellent endothelial secretion of nitric oxide and
other biologically active substances, active thinning (string phenomenon) with
no-flow patency (nonworking collateral vessel), reestablishment of graft flow de-
pending on the myocardial demand, and the phenomenon that we can call the
“self-reparative ability,” as published in this issue of the Journal.7
It has previously been demonstrated that the ITA graft can grow in longitudinal
length and transverse diameter in response to somatic growth of children with
coronary obstruction.8 This is the most clear-cut evidence to show that the ITA graft
is a viable structure. Moreover, the ITA graft caliber at the anastomotic junction can
also grow in children.9 Probably the same mechanism can work on the stenotic
anastomotic sites in adults, with resultant late reduction in the grade of anastomotic
stenosis located between the ITA graft and the recipient coronary artery, as shown
in the article by Izumi and colleagues.7 Within 14 days after a bypass operation, ITA
flow can show a several-fold increase with a 1.5 times increase in diameter.10 The
ITA graft responds to an acute increase in flow by vasodilatation most importantly
by release of nitric oxide, a potent vasodilator derived from the highly active
endothelium of the ITA11 induced by increased shear stress to the arterial wall.
Shear stress–induced nitric oxide release occurs in a matter of several seconds
through the calcium-dependent constitutive form of nitric oxide synthase activa-
tion.12 The ITA graft can maintain the secretory ability of nitric oxide long after the
bypass operation.13,14 Nitric oxide is released bidirectionally by the endothelium.15
Extraluminal nitric oxide acts on the underlying vascular smooth muscle regulating
the vascular tone and inhibits neointimal proliferation. This action might be effec-
tive in making anastomotic stenoses less fibrotic. Intraluminal nitric oxide is
released into the blood stream and can be demonstrated long after the bypass
operation through activation of the ITA endothelium with acetylcholine.13 Intralu-
minally released nitric oxide protects platelet aggregation and adhesion and might
have a metabolic effect on the downstream vascular beds.16 In this sense I think we
can call ITA grafting autologous transplantation of the good-quality arterial endo-
thelium into the coronary circulation that has impaired endothelial function with
atherosclerosis.13 Excellent nitric oxide production of the ITA endothelium will
prevent further atherosclerotic process for both grafts and grafted coronary arteries,
and as a matter of fact, atherosclerotic progression of the coronary artery distal to
the ITA graft anastomosis is infrequent.17 In addition, following revascularization
with ITA grafts, coronary vasospastic response to ergonovine is significantly ame-
liorated or disappears at the segment distal to the ITA graft anastomosis. This
phenomenon has been documented by angiography with pharmacologic interven-
tion18 and can be considered as a proof of the beneficial metabolic effect of the ITA
graft, that is an antispastic effect of the ITA graft on vasospastic coronary arteries.
ITA grafts act differently from vein grafts on progression of grafted coronary
artery stenosis proximal to the anastomosis. Angiographic progression of grafted
coronary artery stenosis is 18% for ITA grafts versus 46% for vein grafts in one







Lseries,3 and 26% versus 45%,19 12% versus 38%,20 and
39% versus 67%17 in other series. These differences are all
statistically significant. Progression occurs less frequently
in coronary arterial segments bypassed with ITA grafts than
in those bypassed with vein grafts. This fact is believed to
be attributed to characteristics of the viable ITA graft’s
function as a major collateral channel. On the basis of these
facts, I believe that the ITA graft has a potential metabolic
effect that protects the grafted coronary arteries from vaso-
spastic responses and atherosclerotic progression, resulting
in longer survival of the patients with more ITA grafts than
those without ITA grafts.21 This salutary metabolic effect of
the ITA graft cannot be expected from coronary stents
alone. In the present article by Izumi and colleagues,7 the
physiologic response and adaptability of the ITA graft is
again demonstrated in terms of the self-reparative ability
that can be expected only in a viable graft.
This article also gives rise to an important clinical issue,
particularly in the era of off-pump coronary artery bypass,
during which anastomotic complications possibly increase.
The issue is whether early postoperative angiographic con-
firmation is needed more than before in the off-pump cor-
onary artery bypass era. Early postoperative angiographic
assessment is rather common in Japan but not so in Western
counterparts, mainly because of the difference in social
insurance coverage. According to the present report, early
postoperative angiography is not necessary for the purpose
of evaluating ITA graft anastomosis unless the patient
shows some types of myocardial ischemia. In addition,
intraoperative measurements and evaluation of graft flow
with its pattern analysis can provide relatively accurate
clues to detect anastomotic failure during an operation. With
this technology, surgeons can handle it inside the operating
room. In other words, as long as the ITA is adequately
handled and anastomosed in the operating room, there is not
much to worry about with regard to ITA graft status there-
after. This is certainly good information for surgeons. Also,
cardiologists who perform early angiography for the pur-
pose of their own confirmation and sometimes evaluation of
surgeons should also realize this fact. However, when a
tight (80%-90%) anastomotic stenosis is found at angiog-
raphy performed for any reason, I believe that balloon
dilatation should be applied because this procedure is safe
and long lasting22 and might prevent the ITA graft occlusion
(thrombosis) that occurs at the rate of a few percent, usually
as a result of some technical mishap. Simple balloon dila-
tation is quite satisfactory, with no need for stenting.
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